Acta Chir Orthop Traumatol Cech. 2016; 83(4):254-262 | DOI: 10.55095/achot2016/041

Intra-Articular Application of Tranexamic Acid Significantly Reduces Blood Loss and Transfusion Requirement in Primary Total Knee ArthroplastyOriginal papers

J. LO©«ÁK1, J. GALLO1,*, J. ©PIČKA1, K. LANGOVÁ2
1 Ortopedická klinika Lékařské fakulty Univerzity Palackého v Olomouci a Fakultní nemocnice Olomouc
2 Ústav lékařské biofyziky Lékařské fakulty Univerzity Palackého v Olomouci

PURPOSE OF THE STUDY:
The aim of this prospective study was to investigate the effect of topical application of tranexamic acid (TXA, Exacyl) on the amount of post-operative blood loss, and blood transfusion requirement in patients undergoing primary total knee arthroplasty (TKA). Attention was paid to early complications potentially associated with TXA administration, such as haematoma, wound exudate, or knee swelling. In addition, the economic benefit of TXA treatment was also taken into account.

MATERIAL AND METHODS:
The study included 238 patients (85 men and 153 women) who underwent primary total knee arthroplasty (TKA) at our department between January 2013 and November 2015. A group of 119 patients (41 men and 78 women) received intra-articular TXA injections according to the treatment protocol (TXA group). A control group matched in basic characteristics to the TXA group also consisted of 119 patients. The average age in the TXA group was 69.8 years, and the most frequent indication for TKA surgery was primary knee osteoarthritis (81.5%). In each patient, post-operative volume of blood lost from drains and total blood loss including hidden blood loss were recorded, as well as post-operative haemoglobin and haematocrit levels. On discharge of each patient from hospital, the size and site of a haematoma; wound exudate, if present after post-operative day 4; joint swelling; range of motion and early revision surgery, if performed, were evaluated. Requirements of analgesic drugs after surgery were also recorded.

RESULTS:
In the TXA group, blood losses from drains were significantly lower than in the control group (456.7 ± 270.8 vs 640.5 ±448.2; p = 0.004). The median value for blood losses from drains was lower by 22% and the average value for total blood loss, including hidden losses, was also lower than in the control group (762.4 ± 345.2 ml vs 995.5 ± 457.3 ml). The difference in the total amount of blood loss between the two groups was significant (p = 0.0001), including hidden blood loss (p = 0.030). The TXA patients had significantly fewer requirements for allogeneic blood transfusion (p < 0.0004), higher post-operative haemoglobin levels (p = 0.014), lower incidence of haematomas (p = 0.0003), and a significantly higher flexion degree on discharge from hospital (p < 0.0001). No higher volume of wound drainage was found (p = 1.000). Only one patient of the TXA group underwent revision surgery due to wound healing disturbance. The total costs of blood transfusion requirements were significantly lower in the TXA group than in the control group (p = 0.0004).

DISCUSSION:
Topical administration allows the antifibrinolytic effect of TXA to act directly at a bleeding site. Its advantages involve easy application, maximum TXA concentration at the site of application, no danger associated with administration of a higher TXA dose and minimal TXA resorption into the circulation. On the other hand, there are no exact instructions for an effective and safe topical application of TXA and some authors are concerned that a coagulum arising after TXA application might affect soft tissue behaviour (healing, swelling, rehabilitation) or result in infection.

CONCLUSIONS:
The study showed the efficacy and safety of topical TXA administration resulting in lower peri-operative bleeding, fewer blood transfusion requirements and higher haemoglobin levels after TKA. The patients treated with TXA had less knee swelling, lower incidence of haematomas and used fewer analgesic drugs in the early post-operative period. The economic benefit is also worth considering. In agreement with the recent literature, it is suggested to add topical TXA application to the recommended procedures for TKA surgery.

Keywords: tranexamic acid, Exacyl, topical application, intra-articular application, blood loss, hidden blood loss, total knee arthroplasty, complications

Published: August 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
LO©«ÁK J, GALLO J, ©PIČKA J, LANGOVÁ K. Intra-Articular Application of Tranexamic Acid Significantly Reduces Blood Loss and Transfusion Requirement in Primary Total Knee Arthroplasty. Acta Chir Orthop Traumatol Cech. 2016;83(4):254-262. doi: 10.55095/achot2016/041. PubMed PMID: 28026726.
Download citation

References

  1. AGUILERA, X., MARTINEZ-ZAPATA, M. J., HINAREJOS, P., JORDAN, M., LEAL, J., GONZALEZ, J. C., MONLLAU, J. C., CELAYA, F., RODRIGUEZ-ARIAS, A., FERNANDEZ, J. A., PELFORT, X., PUIG-VERDIE, L.: Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial. Arch. Orthop. Trauma Surg., 135: 1017-1025, 2015. Go to original source... Go to PubMed...
  2. ALSHRYDA, S., MASON, J., VAGHELA, M., SARDA, P., NARGOL, A., MAHESWARAN, S., TULLOCH, C., ANAND, S., LOGISHETTY, R., STOTHART, B., HUNGIN, A. P.: Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). J. Bone Jt Surg., 95-A:1961-1968, 2013. Go to original source... Go to PubMed...
  3. ALSHRYDA, S., SUKEIK, M., SARDA, P., BLENKINSOPP, J., HADDAD, F. S., MASON, J. M.: A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J., 96-b: 1005-1015, 2014. Go to original source... Go to PubMed...
  4. GEORGIADIS, A. G., MUH, S. J., SILVERTON, C. D., WEIR, R. M., LAKER, M. W.: A prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J. Arthroplasty, 28: 78-82, 2013. Go to original source... Go to PubMed...
  5. GILLETTE, B. P., MARADIT KREMERS, H., DUNCAN, C. M., SMITH, H. M., TROUSDALE, R. T., PAGNANO, M. W., SIERRA, R. J.: Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J. Arthroplasty, 28: 137-139, 2013. Go to original source... Go to PubMed...
  6. GOOD, L., PETERSON, E., LISANDER, B.: Tranexamic acid decreases external blood loss but not hidden blood loss in total knee replacement. Br. J. Anaesth., 90: 596-599, 2003. Go to original source... Go to PubMed...
  7. HILL, G. E., FRAWLEY, W. H., GRIFFITH, K. E., FORESTNER, J. E., MINEI, J. P.: Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J. Trauma, 54: 908-914, 2003. Go to original source... Go to PubMed...
  8. CHEVET, I., REMERAND, F., COUVRET, C., BAUD, A., POUPLARD, C., ROSSET, P., LAFFON, M., FUSCIARDI, J.: [Tranexamic acid reduces haematomas but not pain after total knee arthroplasty]. Ann. Fr. Anesth. Reanim., 30: 17-24, 2011. Go to original source... Go to PubMed...
  9. ISHIDA, K., TSUMURA, N., KITAGAWA, A., HAMAMURA, S., FUKUDA, K., DOGAKI, Y., KUBO, S., MATSUMOTO, T., MATSUSHITA, T., CHIN, T., IGUCHI, T., KUROSAKA, M., KURODA, R.: Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Int. Orthop., 35: 1639-1645, 2011. Go to original source... Go to PubMed...
  10. KUCERA, B., NAHLIK, D., HART, R., OCELAKOVA, L.: [Post-operative retransfusion and intra-operative autotransfusion systems in total knee arthroplasty. A comparison of their efficacy]. Acta Chir. orthop. Traum. čech. 79: 361-366, 2012. Go to original source...
  11. LIN, S. Y., CHEN, C. H., FU, Y. C., HUANG, P. J., CHANG, J. K., HUANG, H. T.: The efficacy of combined use of intraarticular and intravenous tranexamic Acid on reducing blood loss and transfusion rate in total knee arthroplasty. J. Arthroplasty, 30: 776-780, 2015. Go to original source... Go to PubMed...
  12. LOSTAK, J., GALLO, J., ZAPLETALOVA, J.: The evidence for usage of tranexamic acid in patients undergoing primary total hip ane knee arthroplasty. Ortopedie, 10: 2016.
  13. LOSTAK, J., GALLO, J., MLCUCHOVA, D.: [Multivariate analysis of blood loss during primary total hip or knee arthroplasty]. Acta Chir. orthop. Traum. čech., 80: 219-225, 2013. Go to original source...
  14. MANIAR, R. N., KUMAR, G., SINGHI, T., NAYAK, R. M., MANIAR, P. R.: Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin. Orthop. Relat. Res., 470: 2605-2612, 2012. Go to original source... Go to PubMed...
  15. PANTELI, M., PAPAKOSTIDIS, C., DAHABREH, Z., GIANNOUDIS, P. V.: Topical tranexamic acid in total knee replacement: a systematic review and meta-analysis. Knee, 20: 300-309, 2013. Go to original source... Go to PubMed...
  16. PETRLICEK J., S. J., SADOVSKY P., MUSIL D., MEZERA V. : The Effect of Tranexamic Acid on Blood Loss after Primary Unilateral Total Knee Arthroplasty. Prospective single-centre study. Acta Chir. orthop. Traum. čech., 82: 418-423, 2015. Go to original source...
  17. POERAN, J., RASUL, R., SUZUKI, S., DANNINGER, T., MAZUMDAR, M., OPPERER, M., BOETTNER, F., MEMTSOUDIS, S. G.: Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ, 349: g4829, 2014. Go to original source... Go to PubMed...
  18. ROSENCHER, N., KERKKAMP, H. E., MACHERAS, G., MUNUERA, L. M., MENICHELLA, G., BARTON, D. M., CREMERS, S., ABRAHAM, I. L.: Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion, 43: 459-469, 2003. Go to original source... Go to PubMed...
  19. RYBKA, V., VAVŘÍK, P., LANDOR, I., DENK, F., HACH, J., KRŮTA, T., SÍBR, M.: [All-polyethylene tibial component in Walter-Motorlet total knee arthroplasty. Long-term outcomes]. Acta Chir. orthop. Traum. čech., 81: 122-128, 2014. Go to original source...
  20. SA-NGASOONGSONG, P., WONGSAK, S., CHANPLAKORN, P., WORATANARAT, P., WECHMONGKOLGORN, S., WIBULPOLPRASERT, B., MULPRUEK, P., KAWINWONGGOWIT, V.: Efficacy of low-dose intra-articular tranexamic acid in total knee replacement; a prospective triple-blinded randomized controlled trial. BMC Musculoskelet. Disord., 14: 340, 2013. Go to original source... Go to PubMed...
  21. SHEN, P. F., HOU, W. L., CHEN, J. B., WANG, B., QU, Y. X.: Effectiveness and safety of tranexamic acid for total knee arthroplasty: a prospective randomized controlled trial. Med. Sci. Monit., 21: 576-581, 2015. Go to original source... Go to PubMed...
  22. WANG, C., XU, G. J., HAN, Z., MA, J. X., MA, X. L., JIANG, X., WANG, Y.: Topical application of tranexamic acid in primary total hip arthroplasty: a systemic review and meta-analysis. Int. J. Surg., 15: 134-139, 2015. Go to original source... Go to PubMed...
  23. WONG, J., ABRISHAMI, A., EL BEHEIRY, H., MAHOMED, N. N., RODERICK DAVEY, J., GANDHI, R., SYED, K. A., MUHAMMAD OVAIS HASAN, S., DE SILVA, Y., CHUNG, F.: Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J. Bone Jt Surg., 92-A: 2503-2513, 2010. Go to original source... Go to PubMed...
  24. YANG, Z. G., CHEN, W. P., WU, L. D.: Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J. Bone Jt Surg., 94-A: 1153-1159, 2012. Go to original source... Go to PubMed...
  25. ZHANG, H., CHEN, J., CHEN, F., QUE, W.: The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg. Sports Traumatol. Arthrosc., 20: 1742-1752, 2012. Go to original source... Go to PubMed...